Cullinan Oncology Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
P
|
PriceSmart Inc
F:PS8
|
US |
|
Antibe Therapeutics Inc
TSX:ATE
|
CA |
|
Spirit Airlines Inc
NYSE:SAVE
|
US |
|
G
|
Gentian Diagnostics ASA
OSE:GENT
|
NO |
|
W
|
WW International Inc
XMUN:WW6
|
US |
|
Ryanair Holdings PLC
ISEQ:RYA
|
IE |
|
Ufp Industries Inc
NASDAQ:UFPI
|
US |
|
Security Federal Corp
OTC:SFDL
|
US |
|
Halitron Inc
OTC:HAON
|
US |
|
Cgrowth Capital Inc
OTC:CGRA
|
US |
|
Inversa Prime Socimi SA
MAD:YIPS
|
ES |
|
Geomega Resources Inc
XTSX:GMA
|
CA |
|
Altarea SCA
OTC:ATRRF
|
FR |
|
A
|
Agilysys Inc
F:PS3
|
US |
|
L
|
Lindbergh SpA
MIL:LDB
|
IT |
|
Latrobe Magnesium Ltd
ASX:LMG
|
AU |
|
C
|
City Steel PCL
SET:CITY
|
TH |
|
Intelgenx Technologies Corp
TSX:IGX
|
CA |
|
B
|
Brunello Cucinelli SpA
F:8BU
|
IT |
|
Takashimaya Co Ltd
F:TKM
|
JP |
|
Schindler Holding AG
SIX:SCHP
|
CH |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
F
|
Fiserv Inc
BMV:FISV
|
US |
Wall St Price Targets
CGEM Price Targets Summary
Cullinan Oncology Inc
According to Wall Street analysts, the average 1-year price target for
CGEM is 36.805 USD with a low forecast of 27.27 USD and a high forecast of 55.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CGEM's stock price target?
Price Target
36.805
USD
According to Wall Street analysts, the average 1-year price target for
CGEM is 36.805 USD with a low forecast of 27.27 USD and a high forecast of 55.65 USD.